SEQUENCING OF MEDICAL THERAPY IN HEART FAILURE WITH A REDUCED EJECTION FRACTION

Essex Cardiothoracic Centre, Basildon, UK; Anglia Ruskin University Faculty of Health Education Medicine & Social Care, Chelmsford, UK

The management of heart failure with a reduced ejection fraction is a significant achievement in modern medicine, supported by evidence from clinical trials that highlight various disease-modifying drug treatments. These treatments are crucial for improving both symptoms and survival rates. However, the increasing number of available therapies presents a challenge in ensuring that patients receive these treatments promptly and at the correct dosages. The document outlines strategies for optimizing therapy initiation and titration to minimize mortality risks associated with delayed treatment.